What is the AB-rating for Aurobindo's Quetiapine 300 mg?
Aurobindo's 300 mg quetiapine fumarate extended-release tablets have an AB rating, indicating they are considered therapeutically equivalent to the reference listed drug, Seroquel XR [1]. This rating, assigned by the U.S. Food and Drug Administration (FDA), means that generic versions are expected to have the same clinical effect and safety profile as the original brand-name product.
What does an AB-rating signify for generic drugs?
An AB rating signifies that a generic drug is bioequivalent to its brand-name counterpart. This means the generic drug delivers the same amount of active ingredient into the bloodstream over the same period. This therapeutic equivalence allows for the substitution of generic drugs for brand-name drugs by pharmacists without requiring physician approval in many cases. The FDA's Orange Book is the primary source for identifying approved drug products and their therapeutic equivalence evaluations, including AB ratings [2].
When does the patent for Seroquel XR expire?
The patent protection for Seroquel XR has expired, allowing generic manufacturers like Aurobindo to produce and market their versions of the drug. Information on patent expirations for various drugs, including Seroquel XR, can be found on resources such as DrugPatentWatch.com [3].
How does Aurobindo's Quetiapine compare to Seroquel XR?
Aurobindo's quetiapine fumarate extended-release tablets are designed to be therapeutically equivalent to Seroquel XR. Both products contain quetiapine fumarate as the active ingredient and are formulated for extended-release delivery. The AB rating confirms that they are expected to perform identically in the body [1].
What are the potential reasons for AB-rated generics?
The development of AB-rated generic drugs is driven by the FDA's mandate to ensure access to affordable medications. Generic manufacturers conduct studies to demonstrate bioequivalence to the reference drug. Upon approval, these generics offer patients and healthcare providers more cost-effective treatment options without compromising therapeutic outcomes [2].
Where can I find more information on drug patents and generics?
For detailed information on drug patents, exclusivity periods, and generic drug approvals, resources like DrugPatentWatch.com provide comprehensive databases and analyses. These platforms track patent lifecycles and regulatory statuses for a wide range of pharmaceutical products [3].
Sources:
[1] Aurobindo Pharma USA, Inc. (n.d.). Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg. Retrieved from https://www.aurobindo.com/media/filer_public/24/b7/24b7a01a-0e17-443e-a563-2c23746531a7/quetiapine-fumarate-er-tablets-package-insert.pdf
[2] U.S. Food and Drug Administration. (n.d.). Generic Drugs: Questions & Answers. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drugs-questions-answers
[3] DrugPatentWatch.com. (n.d.). Seroquel XR Patent Expirations. Retrieved from https://drugpatentwatch.com/